Comprehensive Evaluation of the Cytotoxic T-Lymphocyte Antigen-4 Gene Polymorphisms in Risk of Bone Sarcoma

Cytotoxic T-Lymphocyte Antigen-4 Genetic Variants and Risk of Ewing's Sarcoma

(2013) Dapeng Feng et al.   Genetic Testing and Molecular Biomarkers

Cytotoxic T-Lymphocyte Antigen-4 Polymorphisms and Susceptibility to Ewing's Sarcoma

(2012) Shufeng Yang et al.   Genetic Testing and Molecular Biomarkers

Cytotoxic T-lymphocyte Antigen-4 Polymorphisms and Susceptibility to Osteosarcoma

(2011) Yang Liu et al.   DNA AND CELL BIOLOGY

Targeted therapies in bone sarcomas: current approach and future directions

(2011) Jessica Lee Yarber et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Cytotoxic T-Lymphocyte Antigen-4 +49G/A Polymorphism Is Associated with Increased Risk of Osteosarcoma

(2011) Wen Wang et al.   Genetic Testing and Molecular Biomarkers

CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer

(2011) Lidia Karabon et al.   HUMAN IMMUNOLOGY

CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers—hepatocellular carcinoma and cervical cancer

(2010) Lingmin Hu et al.   HUMAN IMMUNOLOGY

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?

(2009) Marna G. Bouwhuis et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS